GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » Research & Development

SLS BIO Co (XKRX:246250) Research & Development : ₩591 Mil (TTM As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is SLS BIO Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. SLS BIO Co's Research & Development for the three months ended in Dec. 2024 was ₩175 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was ₩591 Mil.

SLS BIO Co Research & Development Historical Data

The historical data trend for SLS BIO Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SLS BIO Co Research & Development Chart

SLS BIO Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 720.96 628.08 503.70 533.56 591.00

SLS BIO Co Quarterly Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 137.22 132.52 157.53 126.17 174.78

SLS BIO Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩591 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SLS BIO Co  (XKRX:246250) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

SLS BIO Co Research & Development Related Terms

Thank you for viewing the detailed overview of SLS BIO Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

SLS BIO Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » Research & Development
Comparable Companies
XKRX:031860 XKRX:229000 XKRX:221800 XKRX:149300 XKRX:236340 XKRX:303360 XKRX:086460 XKRX:109820 XKRX:086040 XKRX:347740 TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT
Traded in Other Exchanges
N/A
Address
Gwanggyo Central Biz Tower, 7th floor, Changryong-dong 260, Gyeonggi-do, Suwon-si, KOR, 16229
Website
http://www.slabs.co.kr
SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.

SLS BIO Co Headlines

No Headlines